[1] Kazemi S, Pourmadadi M, Yazdian F, Ghadami A. The synthesis and characterization of targeted delivery curcumin using chitosan-magnetite-reduced graphene oxide as nano-carrier. Int J Biol Macromol. 2021;186:554-62. doi:10.1016/j.ijbiomac.2021.06.184.
[2] Pourmadadi M, Ahmadi MJ, Abdouss M, Yazdian F, Rashedi H, Navaei-Nigjeh M, Hesari Y. The synthesis and characterization of double nanoemulsion for targeted Co-Delivery of 5-fluorouracil and curcumin using pH-sensitive agarose/chitosan nanocarrier. J Drug Deliv Sci Technol. 2022;70:102849. doi:10.1016/j.jddst.2021.102849.
[3] Omrani Z, Pourmadadi M, Yazdian F, Rashedi H. Preparation and characterization of pH-sensitive chitosan/starch/MoS2 nanocomposite for control release of curcumin macromolecules drug delivery; application in the breast cancer treatment. Int J Biol Macromol. 2023;250:125897. doi:10.1016/j.ijbiomac.2023.125897.
[4] Shakouri S, Pourmadadi M, Abdouss M, Rahdar A, Pandey S. pH-responsive double emulsion system for targeted anticancer therapy based on polyacrylic acid-polyvinyl pyrrolidone containing carbon nanotubes for 5-fluorouracil as an anticancer medication. Inorg Chem Commun. 2023;158(Part 1):111494. doi:10.1016/j.inoche.2023.111494.
[5] Zoghi M, Pourmadadi M, Yazdian F, Navaei Nigjeh M, Rashedi H, Sahraeian R. Synthesis and characterization of chitosan/carbon quantum dots/Fe2O3 nanocomposite comprising curcumin for targeted drug delivery in breast cancer therapy. Int J Biol Macromol. 2023;249:125788. doi:10.1016/j.ijbiomac.2023.125788.
[6] Eshaghi MM, Pourmadadi M, Rahdar A, Díez-Pascual AM. Improving quercetin anticancer activity through a novel polyvinylpyrrolidone/polyvinyl alcohol/TiO2 nanocomposite. J Drug Deliv Sci Technol. 2023;81:104304. doi:10.1016/j.jddst.2023.104304.
[7] Najafabadi AP, Pourmadadi M, Yazdian F, Rashedi H, Rahdar A, Díez-Pascual AM. pH-sensitive ameliorated quercetin delivery using graphene oxide nanocarriers coated with potential anticancer gelatin-polyvinylpyrrolidone nanoemulsion with bitter almond oil. J Drug Deliv Sci Technol. 2023;82:104339. doi:10.1016/j.jddst.2023.104339.
[8] Rahmani E, Pourmadadi M, Ghorbanian SA, Yazdian F, Rashedi H, Navaee M. Preparation of a pH-responsive chitosan-montmorillonite-nitrogen-doped carbon quantum dots nanocarrier for attenuating doxorubicin limitations in cancer therapy. Eng Life Sci. 2022;22:634-49. doi:10.1002/elsc.202200016.
[9] Abdouss A, Pourmadadi M, Zahedi P, Abdouss M, Yazdian F, Rahdar A, Díez-Pascual AM. Green synthesis of chitosan/polyacrylic acid/graphitic carbon nitride nanocarrier as a potential pH-sensitive system for curcumin delivery to MCF-7 breast cancer cells. Int J Biol Macromol. 2023;242(Part 3):125134. doi:10.1016/j.ijbiomac.2023.125134.
[10] Pourmadadi M, Ahmadi MJ, Yazdian F. Synthesis of a novel pH-responsive Fe3O4/chitosan/agarose double nanoemulsion as a promising Nanocarrier with sustained release of curcumin to treat MCF-7 cell line. Int J Biol Macromol. 2023;235:123786. doi:10.1016/j.ijbiomac.2023.123786.
[11] Bayat F, Pourmadadi M, Eshaghi MM, et al. Improving Release Profile and Anticancer Activity of 5-Fluorouracil for Breast Cancer Therapy Using a Double Drug Delivery System: Chitosan/Agarose/γ-Alumina Nanocomposite@Double Emulsion. J Clust Sci. 2023;34(5):2565-77. doi:10.1007/s10876-023-02405-y.
[12] Rajaei M, Rashedi H, Yazdian F, Navaei-Nigjeh M, Rahdar A, Díez-Pascual AM. Chitosan/agarose/graphene oxide nanohydrogel as drug delivery system of 5-fluorouracil in breast cancer therapy. J Drug Deliv Sci Technol. 2023;82:104307. doi:10.1016/j.jddst.2023.104307.
[13] Pourmadadi M, Darvishan S, Abdouss M, Yazdian F, Rahdar A, Díez-Pascual AM. pH-responsive polyacrylic acid (PAA)-carboxymethyl cellulose (CMC) hydrogel incorporating halloysite nanotubes (HNT) for controlled curcumin delivery. Ind Crops Prod. 2023;197:116654. doi:10.1016/j.indcrop.2023.116654.
[14] Ostovar S, Pourmadadi M, Shamsabadipour A, Mashayekh P. Nanocomposite of chitosan/gelatin/carbon quantum dots as a biocompatible and efficient nanocarrier for improving the Curcumin delivery restrictions to treat brain cancer. Int J Biol Macromol. 2023;242(Part 3):124986. doi:10.1016/j.ijbiomac.2023.124986.
[15] Gerami AE, Pourmadadi M, Fatoorehchi H, Yazdian F, Rashedi H, Nigjeh MN. Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe2O3 nanocomposite for drug delivery application: Emphasis on ameliorating restrictions. Int J Biol Macromol. 2021;173:409-20. doi:10.1016/j.ijbiomac.2021.01.067.
[16] Samadi A, Pourmadadi M, Yazdian F, Rashedi H, Navaei-Nigjeh M, Eufrasio-da-silva T. Ameliorating quercetin constraints in cancer therapy with pH-responsive agarose-polyvinylpyrrolidone-hydroxyapatite nanocomposite encapsulated in double nanoemulsion. Int J Biol Macromol. 2021;182:11-25. doi:10.1016/j.ijbiomac.2021.03.146.
[17] Ematollahi E, Pourmadadi M, Yazdian F, Fatoorehchi H, Rashedi H, Navaei Nigjeh M. Synthesis and characterization of chitosan/polyvinylpyrrolidone coated nanoporous γ-Alumina as a pH-sensitive carrier for controlled release of quercetin. Int J Biol Macromol. 2021;183:600-13. doi:10.1016/j.ijbiomac.2021.04.160.
[18] Darvishan S, Pourmadadi M, Abdouss M, Mazinani S, Yazdian F, Rahdar A, Díez-Pascual AM. Gamma alumina coated-PAA/PVP hydrogel as promising quercetin nanocarrier: Physiochemical characterization and toxicity activity. J Drug Deliv Sci Technol. 2023;84:104500. doi:10.1016/j.jddst.2023.104500.
[19] Pourmadadi M, Aslani A, Abdouss M. Synthesis and characterization of biological macromolecules double emulsion based on carboxymethylcellulose/gelatin hydrogel incorporated with ZIF-8 as metal organic frameworks for sustained anti-cancer drug release. Int J Biol Macromol. 2023;243:125168. doi:10.1016/j.ijbiomac.2023.125168.
[20] Eshaghi MM, Pourmadadi M, Ebrahimi SA, Diez-Pascual AM. Improving quercetin anti-cancer activity by embedding into a polyvinylpyrrolidone/polyvinyl alcohol/TiO2 nanocomposite. J Drug Deliv Sci Technol. 2023;81:104304. doi:10.1016/j.jddst.2023.104304.
[21] Darvishan S, Pourmadadi M, Abdouss M, Mazinani S, Yazdian F, Rahdar A, Díez-Pascual AM. Gamma alumina coated-PAA/PVP hydrogel as promising quercetin nanocarrier: Physiochemical characterization and toxicity activity. J Drug Deliv Sci Technol. 2023;84:104500. doi:10.1016/j.jddst.2023.104500.
[22] Parvaneh S, Pourmadadi M, Abdouss M, Pourmousavi SA, Yazdian F, Rahdar A, Díez-Pascual AM. Carboxymethyl cellulose/starch/reduced graphene oxide composite as a pH-sensitive nanocarrier for curcumin drug delivery. Int J Biol Macromol. 2023;241:124566. doi:10.1016/j.ijbiomac.2023.124566.
[23] Eshaghi M, Pourmadadi M, Rahdar A, Díez-Pascual AM. Novel Carboxymethyl Cellulose-Based Hydrogel with Core–Shell Fe3O4@SiO2 Nanoparticles for Quercetin Delivery. Materials. 2022;15:8711. doi:10.3390/ma15248711.
[24] Ahmadi MJ, Pourmadadi M, Ghorbanian SA, Yazdian F, Rashedi H. Ultra pH-sensitive nanocarrier based on Fe2O3/chitosan/montmorillonite for quercetin delivery. Int J Biol Macromol. 2021;191:738-745. doi:10.1016/j.ijbiomac.2021.09.023.
[25] Haseli S, Pourmadadi M, Samadi A, et al. A novel pH-responsive nanoniosomal emulsion for sustained release of curcumin from a chitosan-based nanocarrier: Emphasis on the concurrent improvement of loading, sustained release, and apoptosis induction. Biotechnol Prog. 2022;38(5). doi:10.1002/btpr.3280.
[26] Sabzini M, Pourmadadi M, Yazdian F, Khadiv-Parsi P, Rashedi H. Development of chitosan/halloysite/graphitic-carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells. Int J Biol Macromol. 2023;226:159-171. doi:10.1016/j.ijbiomac.2022.11.189.
[27] Karami MH, Pourmadadi M, Abdouss M, Kalaee MR, Moradi O, Rahdar A, Díez-Pascual AM. Novel chitosan/γ-alumina/carbon quantum dot hydrogel nanocarrier for targeted drug delivery. Int J Biol Macromol. 2023;251:126280. doi:10.1016/j.ijbiomac.2023.126280.
[28] Karami MH, Abdouss M, Kalaee MR, Moradi O. A Review of Hydrogels Containing Fibers in Drug Delivery Systems: A review study. Iran Polymer Technology, Research and Development. In Press, 2023.
[29] Karami MH, Abdouss M, Kalaee M, Moradi O. Chitosan-Based Nanocarriers For The Release Of The Anticancer Drug Curcumin: A Review. Nashrieh Shimi va Mohandesi Shimi Iran. 2023; In Press.
[30] Karami MH, Abdouss M, Kalaee MR, Moradi O. Application of Hydrogel Nanocomposites in Biotechnology: A review study. Iran Polymer Technology, Research and Development. In Press, 2023. doi:10.1001.1.25383345.1402.8.1.3.5.
[31] Karami MH, Abdouss M, Kalaee MR, Moradi O. Investigating the Antibacterial Properties of Chitosan Nanocomposites Containing Metal Nanoparticles For Using in Wound Healings: A Review Study. Basparesh. 2023; In Press. doi:10.22063/basparesh.2023.3285.1648.
[32] Karami MH, Abdouss M, Kalaee MR, Moradi O. The application of chitosan-based nanocarriers in improving the release of the anticancer drug quercetin: a review study. Nano World. 2023; 19(70):21-11. doi:10.1001.1.24765945.1402.19.70.2.5.
[34] Dabiri G, Damstetter E, Phillips T. Choosing a Wound Dressing Based on Common Wound Characteristics. Adv Wound Care. 2016;5:32-41. doi:10.1089/wound.2014.0603.
[35] Du X, Zhou J, Shi J, Xu B. Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials. Chem Rev. 2015;115:13165-13307. doi:10.1021/acs.chemrev.5b00112.
[36] Bashir S, Hina M, Iqbal J, Rajpar AH, Mujtaba MA, Alghamdi NA, Wageh S, Ramesh K, Ramesh S. Fundamental Concepts of Hydrogels: Synthesis, Properties, and Their Applications. Polymers. 2020;12:2702. doi:10.3390/polym12112702.
[37] Rebers L, Reichsöllner R, Regett S, Tovar G, Borchers K, Baudis S, Southan A. Differentiation of physical and chemical cross-linking in gelatin methacryloyl hydrogels. Sci Rep. 2021;11:3256. doi:10.1038/s41598-021-82614-2.
[38] Morello G, Polini A, Scalera F, Rizzo R, Gigli G, Gervaso F. Preparation and Characterization of Salt-Mediated Injectable Thermosensitive Chitosan/Pectin Hydrogels for Cell Embedding and Culturing. Polymers. 2021;13:2674. doi:10.3390/polym13162674.
[39] O’Meara S, Martyn-St James M, Adderley UJ. Alginate dressings for venous leg ulcers. Cochrane Database Syst Rev. 2015;(2015). doi:10.1002/14651858.CD010182.pub2.
[40] Chang NS, Lin R, Sze CI, Aqeilan RI. Editorial: WW Domain Proteins in Signaling, Cancer Growth, Neural Diseases, and Metabolic Disorders. Front Oncol. 2019;9:719. doi:10.3389/fonc.2019.00719.
[41] Brown BN, Badylak SF. Extracellular matrix as an inductive scaffold for functional tissue reconstruction. Transl Res. 2014;163(4):268-285. doi:10.1016/j.trsl.2013.11.010.
[42] Zhang X, Tan B, Wu Y, Zhang M, Liao J. A Review on Hydrogels with Photothermal Effect in Wound Healing and Bone Tissue Engineering. Polymers. 2021;13(12):2100. doi:10.3390/polym13122100.
[43] Verhelst S, Bonger KM, Willems LI. Bioorthogonal Reactions in Activity-Based Protein Profiling. Molecules. 2020;25(26):5994. doi:10.3390/molecules25265994.
[44] Gupta A, Briffa SM, Swingler S, Gibson H, Kannappan V, Adamus G, Kowalczuk M, Martin C, Radecka I. Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose-Based Hydrogels for Wound Dressing Applications. Biomacromolecules. 2020;21(5):1802-1811. doi:10.1021/acs.biomac.0c00113.
[45] Nešović K, Janković A, Kojić V, Vukašinović-Sekulić M, Perić-Grujić A, Rhee KY, Mišković-Stanković V. Silver/poly(vinyl alcohol)/chitosan/graphene hydrogels—Synthesis, biological and physicochemical properties and silver release kinetics. Compos Part B Eng. 2018;154:175-185. doi:10.1016/j.compositesb.2018.08.014.
[46] Sun A, He X, Li L, Li T, Liu Q, Zhou X, Ji X, Li W, Qian Z. An injectable photopolymerized hydrogel with antimicrobial and biocompatible properties for infected skin regeneration. NPG Asia Mater. 2020;12:25. doi:10.1038/s41427-020-0215-8.
[47] Echalier C, Laurine V, Martinez J, Mehdi A, Gilles S. Chemical cross-linking methods for cell encapsulation in hydrogels. Materials Today Communications. 2019;20:100536. doi:10.1016/j.mtcomm.2019.100536.
[48] Xin H, Biswas N, Li P, Zhong C, Chan TC, Nudleman E, Ferrara N. Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders. Proc Natl Acad Sci U S A. 2021;118(5). doi:10.1073/pnas.1921252118.
